XENETIC BIOSCIENCES, INC. Interest Income (Expense), Net
XENETIC BIOSCIENCES, INC. (XBIO) reported Interest Income (Expense), Net of $148.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2026-03-12
- XENETIC BIOSCIENCES, INC. interest income (expense), net for the quarter ending 2025-12-31 was $43.79K, a 15.57% decline year-over-year.
- XENETIC BIOSCIENCES, INC. interest income (expense), net for the quarter ending 2025-09-30 was $30.78K, a 49.78% decline year-over-year.
- XENETIC BIOSCIENCES, INC. interest income (expense), net for the quarter ending 2025-06-30 was $34.23K, a 46.05% decline year-over-year.
- XENETIC BIOSCIENCES, INC. interest income (expense), net for the quarter ending 2025-03-31 was $39.19K, a 46.50% decline year-over-year.
- XENETIC BIOSCIENCES, INC. interest income (expense), net for fiscal 2025 was $148.00K, a 40.77% decline from fiscal 2024.
- XENETIC BIOSCIENCES, INC. interest income (expense), net for fiscal 2024 was $249.86K, a 29.77% decline from fiscal 2023.
- XENETIC BIOSCIENCES, INC. interest income (expense), net for fiscal 2023 was $355.76K, a 112.83% increase from fiscal 2022.
- XENETIC BIOSCIENCES, INC. interest income (expense), net for fiscal 2022 was $167.15K, a 66.38% increase from fiscal 2021.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2025-12-31 | $43.79K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $74.58K derived: sum of 2 quarters · filed 2026-03-12 | $108.81K derived: sum of 3 quarters · filed 2026-03-12 | $148.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $30.78K 10-Q · filed 2025-11-12 | $65.02K derived: sum of 2 quarters · filed 2025-11-12 | $104.20K 10-Q · filed 2025-11-12 | $156.07K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $34.23K 10-Q · filed 2025-08-12 | $73.42K 10-Q · filed 2025-08-12 | $125.29K derived: sum of 3 quarters · filed 2026-03-12 | $186.59K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $39.19K 10-Q · filed 2025-05-13 | $91.06K derived: sum of 2 quarters · filed 2026-03-12 | $152.35K derived: sum of 3 quarters · filed 2026-03-12 | $215.80K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $51.87K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $113.17K derived: sum of 2 quarters · filed 2026-03-12 | $176.61K derived: sum of 3 quarters · filed 2026-03-12 | $249.86K 10-K · filed 2026-03-12 |
| 2024-09-30 | $61.30K 10-Q · filed 2025-11-12 | $124.75K derived: sum of 2 quarters · filed 2025-11-12 | $197.99K 10-Q · filed 2025-11-12 | $281.75K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $63.45K 10-Q · filed 2025-08-12 | $136.70K 10-Q · filed 2025-08-12 | $220.45K derived: sum of 3 quarters · filed 2025-08-12 | $312.25K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $73.25K 10-Q · filed 2025-05-13 | $157.01K derived: sum of 2 quarters · filed 2025-05-13 | $248.80K derived: sum of 3 quarters · filed 2025-05-13 | $374.90K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $83.76K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $175.55K derived: sum of 2 quarters · filed 2025-03-18 | $301.66K derived: sum of 3 quarters · filed 2025-03-18 | $355.76K 10-K · filed 2025-03-18 |
| 2023-09-30 | $91.80K 10-Q · filed 2024-11-12 | $217.90K derived: sum of 2 quarters · filed 2024-11-12 | $272.00K 10-Q · filed 2024-11-12 | $351.81K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $126.10K 10-Q · filed 2024-08-13 | $180.20K 10-Q · filed 2024-08-13 | $260.01K derived: sum of 3 quarters · filed 2024-08-13 | $305.49K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $54.10K 10-Q · filed 2024-05-09 | $133.91K derived: sum of 2 quarters · filed 2024-05-09 | $179.38K derived: sum of 3 quarters · filed 2024-05-09 | $195.35K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $79.81K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $125.28K derived: sum of 2 quarters · filed 2024-03-21 | $141.25K derived: sum of 3 quarters · filed 2024-03-21 | $167.15K 10-K · filed 2024-03-21 |
| 2022-09-30 | $45.48K 10-Q · filed 2023-11-09 | $61.44K derived: sum of 2 quarters · filed 2023-11-09 | $87.34K 10-Q · filed 2023-11-09 | $116.79K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $15.96K 10-Q · filed 2023-08-10 | $41.87K 10-Q · filed 2023-08-10 | $71.31K derived: sum of 3 quarters · filed 2023-08-10 | $99.34K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $25.91K 10-Q · filed 2023-05-11 | $55.35K derived: sum of 2 quarters · filed 2023-05-11 | $83.38K derived: sum of 3 quarters · filed 2023-05-11 | $104.11K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $29.44K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $57.47K derived: sum of 2 quarters · filed 2023-03-22 | $78.20K derived: sum of 3 quarters · filed 2023-03-22 | $100.47K 10-K · filed 2023-03-22 |
| 2021-09-30 | $28.03K 10-Q · filed 2022-11-09 | $48.76K derived: sum of 2 quarters · filed 2022-11-09 | $71.03K 10-Q · filed 2022-11-09 | $92.15K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $20.73K 10-Q · filed 2022-08-11 | $43.00K 10-Q · filed 2022-08-11 | $64.13K derived: sum of 3 quarters · filed 2022-08-11 | $89.06K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $22.26K 10-Q · filed 2022-05-12 | $43.39K derived: sum of 2 quarters · filed 2022-05-12 | $68.32K derived: sum of 3 quarters · filed 2022-05-12 | $96.95K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $21.13K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $46.06K derived: sum of 2 quarters · filed 2022-03-22 | $74.68K derived: sum of 3 quarters · filed 2022-03-22 | $126.17K 10-K · filed 2022-03-22 |
| 2020-09-30 | $24.93K 10-Q · filed 2021-11-12 | $53.56K derived: sum of 2 quarters · filed 2021-11-12 | $105.04K 10-Q · filed 2021-11-12 | $166.60K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $28.63K 10-Q · filed 2021-08-12 | $80.11K 10-Q · filed 2021-08-12 | $141.67K derived: sum of 3 quarters · filed 2021-08-12 | $188.29K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $51.49K 10-Q · filed 2021-05-11 | $113.05K derived: sum of 2 quarters · filed 2021-05-11 | $159.66K derived: sum of 3 quarters · filed 2021-05-11 | $159.83K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $61.56K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $108.18K derived: sum of 2 quarters · filed 2021-03-16 | $108.34K derived: sum of 3 quarters · filed 2021-03-16 | $108.49K 10-K · filed 2021-03-16 |
| 2019-09-30 | $46.62K 10-Q · filed 2020-11-12 | $46.78K derived: sum of 2 quarters · filed 2020-11-12 | $46.93K 10-Q · filed 2020-11-12 | $47.02K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $163.00 10-Q · filed 2020-08-12 | $313.00 10-Q · filed 2020-08-12 | $398.00 derived: sum of 3 quarters · filed 2020-08-12 | $457.00 derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $150.00 10-Q · filed 2020-05-14 | $235.00 derived: sum of 2 quarters · filed 2020-05-14 | $294.00 derived: sum of 3 quarters · filed 2020-05-14 | $233.00 derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $85.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $144.00 derived: sum of 2 quarters · filed 2020-03-26 | $83.00 derived: sum of 3 quarters · filed 2020-03-26 | $509.00 10-K · filed 2020-03-26 |
| 2018-09-30 | $59.00 10-Q · filed 2019-11-14 | -$2.00 derived: sum of 2 quarters · filed 2019-11-14 | $424.00 10-Q · filed 2019-11-14 | -$10.13K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$61.00 10-Q · filed 2019-08-14 | $366.00 10-Q · filed 2019-08-14 | -$10.18K derived: sum of 3 quarters · filed 2019-08-14 | -$10.61K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $427.00 10-Q · filed 2019-05-13 | -$10.12K derived: sum of 2 quarters · filed 2019-05-13 | -$10.55K derived: sum of 3 quarters · filed 2019-05-13 | -$803.00 derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | -$10.55K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$10.97K derived: sum of 2 quarters · filed 2019-03-29 | -$1.23K derived: sum of 3 quarters · filed 2019-03-29 | -$1.82K 10-K · filed 2019-03-29 |
| 2017-09-30 | -$425.00 10-Q · filed 2018-11-09 | $9.32K derived: sum of 2 quarters · filed 2018-11-09 | $8.73K 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $9.74K 10-Q · filed 2018-08-10 | $9.16K 10-Q · filed 2018-08-10 | ||
| 2017-03-31 | -$588.00 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |